This site is intended for healthcare professionals
  • Home
  • /
  • Guidelines
  • /
  • Amyloid transthyretin (ATTR) amyloidosis
  • /
  • Inotersen for treating hereditary transthyretin am...

Inotersen for treating hereditary transthyretin amyloidosis

Read time: 1 mins
Last updated:21st May 2019
Status: Live
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest